Bal Pharma has informed that the 35th Annual General Meeting of the Company is scheduled to be held on 19th September 2022 at 11.30 AM through audio visual means. Notice along with the details of the business to be transacted at the meeting and audited financial statements of the Company for the FY ended 30.03.2022 together with the reports of Directors and auditors there on is being dispatched to shareholders through electronic form. A copy of the unabridged annual report of the Company for the financial year ended 31.03.2022 is enclosed for submission to the exchanges. Annual report for FY2021-22 is also available on its website i.e., www.balpharma.com
The above information is a part of company’s filings submitted to BSE.
